Trial
NCT04913272
Clinical Trial To Evaluate Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With Chronic Kidney Disease Stage IV
Phase IISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Kibow Pharma
Collaborators
—
Condition
Chronic Kidney Disease stage4
Intervention
US-APR2020
Why stopped
Logistics, company reorganization
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-09-19